Manmade seed pods grow in a planting port without additional user input or horticultural knowledge
Anu™, a modular indoor farm and consumable seed pod supply company, has received a $500,000 Phase IIB Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF).
Purdue University alumni Scott Massey and Ivan Ball met while developing NASA-funded, controlled-environment hydroponic chambers. They co-founded Anu, which is a “Food is Medicine bolt-on solution.”
Massey said, “Food is Medicine is an emerging market focused on applying nutrition in clinical, evidence-driven settings and measuring whole-health outcomes. Anu’s agricultural technology therefore becomes healthcare infrastructure.”
The SBIR grant will be used for multi-cavity tooling of the Anu-patented, compostable Plug-and-Grow™ Seed Pods which are shelf-stable. The seed pods, to be manufactured at Goodwill of Central & Southern Indiana, are preloaded with seeds and nutrients; seed varieties include leafy green vegetables, fruiting plants, herbs and flowers.
Pods plug into a planting port, are water activated by the automated growing system, and grow without additional user input or horticultural knowledge.
“This presents an order-of-magnitude labor improvement for indoor farming,” Massey said. “It consolidates skilled-labor-intensive agronomy, nutrients and nursery seedling germination management into a turnkey consumable usable in both Anu systems as well as hydroponic systems agnostically through Open Garden Upgrade.”
“Multi-cavity seed pod production makes decentralized Food is Medicine programs easier to deploy, replicate and expand across health ecosystems, now supported with our unconstrained, automated manufacturing line capable of producing millions of seed pods annually.”
The grant also supports testing to quantify the nutritional quality of Anu-grown Pure Produce® grown closer to consumption. Massey said previous testing showed it has approximately twice the average nutrient density of store-bought equivalent red leaf lettuce varieties, with certain nutrients such as Vitamin B measuring as much as 10 times higher.
“The Phase IIB work will expand this evidence base as Anu scales its Food is Medicine platform where the objective is not simply to produce more food, but to reliably produce and validate the nutritional outcomes healthcare providers are ultimately seeking,” he said.
The Phase IIB grant follows Anu’s NSF SBIR Phase I and II grants for $256,000 and $970,993, respectively, and matching funding from Elevate Ventures. The company also received financial support from Purdue Research Foundation.
Food is Medicine efforts
Massey said rather than ask a hospital or clinic to become an expert farmer, Anu provides a standardized, automated cultivation platform that delivers food-production outcomes predictably and with dramatically less specialized agricultural labor.
“Anu’s manufactured seed pods are designed to abstract those agricultural inputs into a standardized consumable,” he said. “This enables controlled-environment cultivation to be overseen by existing health and nutrition professionals, including dietitians.”
Massey said the pods also can be operated by non-specialist labor such as a student apprentice, rather than a dedicated, skilled agricultural manager.
“Our solution reconnects society broadly to sustainably growing the most flavorful and nutritious food,” he said. “The massive leap in labor efficiency also conserves time and empowers all people to grow Pure Produce.”
Massey said the Phase IIB award therefore scales more than a manufacturing process.
“Our long-term objective is to convert controlled-environment agriculture from a skilled-labor-intensive, outcome-driven production business into a standardized outcome-driven system,” he said. “Plug-and-Grow Seed Pods provide the agronomic inputs, Anu cultivation systems control the growing environment, and healthcare and education partners can focus their labor on nutrition, patient engagement, learning and measured outcomes.”
CARMEL, Ind. & AURORA, Ohio. (October 6, 2026) — SEPRO Scientific and Oase today announced the signing of a Memorandum of Understanding establishing a strategic partnership to expand access to innovative surface water technology solutions for customers across the United States and Canada.
The partnership brings together Oase’s technology and product knowledge with SEPRO Scientific’s field and technical expertise, proven capabilities, and long-standing commitment to water stewardship.
Together, the companies will focus on helping customers address complex surface water challenges with technologies supported by practical expertise and science-led management strategies. The initial collaboration will focus on professional water management applications that support the protection and restoration of surface water.
“Our focus is helping customers make informed decisions and achieve better outcomes through science-led solutions,” said Tyler Koschnick, president and CEO of SEPRO Scientific.“Oase brings strong technological and manufacturing capabilities, while SEPRO Scientific brings decades of water management experience and a practical understanding of how solutions perform in real-world conditions. Together, we expand the tools available to water professionals and provide the technical support needed to implement them effectively.”
The partnership is designed to evolve alongside customer and environmental needs. As the relationship develops, SEPRO Scientific and Oase plan to evaluate additional technologies and applications that can help water professionals address emerging water quality and aquatic ecosystem challenges.
“SeDox Max and SchlixX Plus give us a strong starting point, but the real value of this partnership is helping even more customers accelerate improvements in water quality and sediment health,” said Jeremy Sweet,Chief Sales Officer, Water Technology, Oase. “SEPRO’s technical expertise and established field network bring our restoration solutions directly to the professionals who manage lakes and ponds every day. Together, we can extend the benefits of waterbody restoration across North America.”
Purpose-built research, incubator and laboratory space will leverage Purdue’s R1 capabilities and Elanco’s animal health leadership to advance One Health innovation in Indianapolis
INDIANAPOLIS, Ind. (October 6, 2026) – The One Health Innovation District today unveiled plans for the One Health Research Institute, a new hub for research, collaboration and innovation within the District. Anchored by Purdue University and Elanco Animal Health Incorporated (NYSE: ELAN), the Research Institute will accelerate One Health discovery, diagnostics, translational science and commercialization through advanced research, incubator and laboratory space.
The planned 150,000 square foot, shared-use facility will include advanced research laboratories, shared research infrastructure and equipment and collaboration space, and facilities supporting animal health and veterinary partners. Purdue will serve as the Research Institute’s academic and research anchor – connecting faculty, students, researchers and University capabilities with industry and entrepreneurial partners. Elanco will serve as the industry and innovation anchor – bringing animal health expertise, scientific talent and a direct connection to the development and commercialization of new One Health solutions.
Aligned with Purdue’s strengths in One Health, translational science and data-driven innovation, the One Health Research Institute will create a collaborative environment focused on the interconnected health of people, animals, plants and the environment. The building is designed to bring researchers, clinicians, industry partners and entrepreneurs together to help accelerate the translation of discoveries into new therapeutics, diagnostics, digital health solutions, sustainable agricultural technologies and commercial products.
“The One Health Innovation District fits squarely into both Purdue’s historic land-grant mission and our present-day position as the state’s research and technology flagship university,” said Mitch Daniels, interim president of Purdue University. “And it represents the next big step in expanding Purdue’s presence in Indianapolis and contribution to Indiana’s economic vitality.”
Located adjacent to Elanco’s global headquarters along the White River, the One Health Research Institute represents an important next step in the physical development of the One Health Innovation District and in establishing Indianapolis as a global destination for One Health research, talent, investment and innovation.
“Just one year after Elanco opened our new global headquarters within the One Health Innovation District, today is an exciting milestone in our vision to create a collaborative destination for innovators,” said Jeff Simmons, president and CEO of Elanco. “When you combine the R1 University capabilities of Purdue with the industry expertise we have across all sectors of One Health – Indianapolis is better positioned than ever to deliver best-in-class innovations across animal, human and plant health with unprecedented speed and scale.”
The Research Institute will also provide capacity for additional companies, entrepreneurs, researchers and industry collaborators to locate within the Institute and participate in the district’s innovation ecosystem.
The One Health Innovation District is being intentionally developed to connect research, diagnostics, clinical trials, continuing education, manufacturing, entrepreneurship and commercialization in one environment – helping partners share knowledge, remove barriers and accelerate outcomes. The District is already attracting strong interest from companies seeking to establish a presence alongside Purdue and Elanco, with multiple memoranda of understanding signed. Individual company announcements will follow as plans are finalized.
INDIANAPOLIS—Oct. 1, 2026 – Corteva, Inc. (NYSE: CTVA) today announced it has successfully spun off its advanced seed and genetics business and will move forward as a leading, pure-play global crop protection company.
“This is a new day for Corteva, and we couldn’t be more excited as we move forward with greater focus, agility and a renewed commitment to innovation and operational excellence,” said Corteva CEO Luke Kissam. “As the challenges facing agriculture continue to evolve, we’re ready to meet the needs of the future with the industry’s best people, portfolio and pipeline—advancing safe, effective and sustainable solutions that
deliver for farmers, our channel partners and our shareholders.”
Corteva begins this next chapter with strong momentum and a proven record of excellence in execution. Between 2020 and 2025, the crop protection business increased revenue by over $1 billion while expanding operating EBITDA margins by approximately 250 basis points on a segment basis. This progress includes establishment of an industry-leading biologicals and natural products platform, and intentional evolution of the company’s product mix toward differentiated technologies—now representing ~65% of sales—to bring new, critically-needed innovations to farmers.
With an $11 billion crop protection pipeline, world-class R&D capabilities, including our microbial discovery, integrated development, and predictive safety platforms, Corteva’s future growth will be driven by innovation farmers need most. Today, the company’s nearly 9,000 employees serve growers in approximately 110 countries.
Farm management today looks very different than it did a decade ago, with rising complexity, shifting client expectations and new technology reshaping how decisions get made. In this episode, Howard Halderman, president of Halderman Farm Management, shares how his team is thinking about AI, where it is already improving operations and why human judgment still matters in managing one of agriculture’s most important assets.